Despite aggressive primary surgical cytoreduction and platinum-based chemotherapy, many women diagnosed with advanced epithelial ovarian cancer who achieve primary remission will experience disease ...

Dec. 9, 2004 — Secondary cytoreduction for advanced ovarian cancer does not improve survival, according to the results of a randomized study published in the Dec. 9 issue of the New England Journal of ...

Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy We identified published studies from 1983 to ...

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia ...

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than ...

Oliver Zivanovic and Dennis S. Chi, Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA Disclosure: The authors have no ...

As ovarian cancer is usually diagnosed at an advanced stage, it is associated with a poor prognosis. The initial standard treatment is surgery, with the aim of debulking the primary carcinoma and ...

National guidelines recommend primary surgery as the preferred initial treatment for advanced ovarian cancers despite studies showing less perioperative morbidity with neoadjuvant chemotherapy ...

Ovarian cancer is the 5 th leading cancer killer amongst women, and mortality rates have remained largely unchanged over the past three decades. The current standard of care is cytoreductive surgery, ...

We present a case of a woman in her 50s with a rapidly expanding giant serous cystadenofibroma of the ovary. The 40-kg mass displaced her bowel and splinted her diaphragm, causing mass effect and ...

You know, I really count my successes as ones where I can help that patient live a long, healthy life and keep coming to see me every three to six months. HIPEC is a essentially a treatment that we ...

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than ...